Advisor Partners II’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	$292K	Buy	1,646 +338	+26%	+$59.9K	0.01%	974
2023 Q2	$248K	Buy	+1,308	New	+$248K	0.01%	892
2023 Q1	–	Sell	-1,086	Closed	-$258K	–	1005
2022 Q4	$258K	Buy	+1,086	New	+$258K	0.02%	747